The estimated Net Worth of Lucile Blaise is at least $1.9 Million dollars as of 15 November 2022. Lucile Blaise owns over 516 units of Resmed stock worth over $1,897,912 and over the last 2 years Lucile sold RMD stock worth over $0.
Lucile has made over 1 trades of the Resmed stock since 2022, according to the Form 4 filled with the SEC. Most recently Lucile exercised 516 units of RMD stock worth $116,193 on 15 November 2022.
The largest trade Lucile's ever made was exercising 516 units of Resmed stock on 15 November 2022 worth over $116,193. On average, Lucile trades about 86 units every 0 days since 2022. As of 15 November 2022 Lucile still owns at least 7,504 units of Resmed stock.
You can see the complete history of Lucile Blaise stock trades at the bottom of the page.
Over the last 22 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace, and David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Resmed executives and other stock owners filed with the SEC include: